The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Ryan here are 2 companies forecasts that I own that give solid quarterly earnings per share and revenue estimates.
For the quarter, Micron (ticker: MU) now sees revenue of $6.2 billion to $6.25 billion, up from a previous forecast of $5.6 billion to $6 billion. The company expects adjusted profits for the quarter of between 93 cents and 98 cents a share, up from a previous estimate of 68 to 82 cents. Under generally accepted accounting principles, Micron now projects 51 to 56 cents a share, up from a previous estimate of 34 to 48 cents.
Micron increased its forecast for non-GAAP gross margin in the quarter to a range of 32% to 33%, from a previous forecast of 30% to 32%. On a GAAP basis, the chip maker now sees gross margin of 26% to 27%, up from a previous call for 24% to 26%.
The updated guidance preceded an appearance by Micron CFO David Zinsner at a virtual technology conference hosted by Morgan Stanley.
AND
Texas Instrument's Chief Financial Officer Rafael Lizardi said it’s still too early to say whether the trade dispute is hurting demand, or if order reductions are a natural cooling off following two years of torrid chip-industry growth.
“Demand is slowing across most markets,” Lizardi said in an interview. “What we’re trying to figure out is, is it just the semiconductor cycle or on top of that do we have end-demand slowing because of macro issues? We don’t know.”
Fourth-quarter profit will be $1.14 to $1.34 a share, the Dallas-based company said Tuesday in a statement, and revenue will be $3.6 billion to $3.9 billion. On average, analysts had predicted earnings of $1.38 a share on sales of $4 billion, according to data compiled by Bloomberg
Even CF's other company issues range bound forward guidance..
Amryt also today published its first quarter results and reported that its revenues for the three months of the end of March rose by 8.7% to $48.4m.
The company said the first quarter of 2021 was was extremely busy and it delivered a number of commercial and regulatory successes during the quarter.
It said its two commercial products, metreleptin and lomitapide, continue to deliver solid growth across a host of metrics including revenue, EBITDA growth, cash generation and market expansion.
Its EBITDA increased by 115% compared to the same quarter in 2020, the company added.
"Given the strong performance of the business during the quarter, we are now increasing our revenue guidance for 2021 from $200-$205m to $205 -$210m excluding any potential contribution from the proposed Chiasma transaction, which represents growth of between 12% - 15% on 2020," Dr Joe Wiley said.
CF hasn’t been involved at board level in Amryt since 2017, but if you’re so keen on their reporting strategy why not simply move your money over there? There is no obligation to publish those revenues, and plenty of reasonable reasons not to, depending on how deals have been structured etc.
These posts are unnecessarily long.....